Soligenix, Inc. (SNGX) financial statements and ratios from SEC XBRL: revenue $119371.00 (TTM), net margin -6925.1%, revenue growth -85.8% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $119371.00 |
| Net Margin | -6925.1% |
| Return on Equity | -154.1% |
| Current Ratio | 2.77 |
| Revenue Growth (YoY) | -85.8% |
| EPS Growth (YoY) | 530.4% |
| Price / Book | 1.28 |
| Price / Sales | 71.11 |
| FCF Yield | -114.8% |
| Sector P/E (Healthcare) | 21.7 |
SNGX overview · SNGX earnings · SNGX KPIs · SNGX investor relations · SNGX ownership · SNGX peers · SNGX filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.